Infectious Diseases Resource Center

Click on the subcategory below to find drug monographs for that particular area.

Ebola Outbreak and Vaccination

A major outbreak of Ebola virus spreads through the West African nations of Guinea and Liberia.

Medicinal Mushrooms: Disease Fighters!

A significant number of modern prescription medications have been derived from mushrooms.

Vaccinating Immunodeficient Patients

Immunization with live viral or bacterial vaccines is known to be hazardous for vulnerable patient populations with serious immunodeficiencies.

Worst Measles Outbreak in 20 Years

Public health officials in Orange County, CA are reporting that a measles outbreak is the worst in two decades.

Noxafil New Formulation

Merck announced that the FDA has approved Noxafil injection, a new formulation of the antifungal agent Noxafil for intravenous (IV) use.

Gene Therapy May "Cure" HIV

Genome editing technology has been safely engineered to help provide resistance to HIV infection.

New Drug Product: Sovaldi

As a component of a combination antiviral treatment regimen for chronic hepatitis C (CHC) genotype 1, 2, 3, or 4 infection.

Chart: Community Acquired Pneumonia

Learn more with this clinical reference.

Videos

News

Particulate Matter Found in Cubicin Vial

Cubist Pharmaceuticals announced a voluntary recall of one lot of Cubicin (daptomycin for injection) 500mg in 10mL vials, following a consumer complaint of particulate matter.

Foodborne Infections Remain Issue Despite Progress

The Centers for Disease Control and Prevention (CDC) reports that although rates for some foodborne infections are on the decline, others remain stagnant or increased in 2013.

MRSA Isolate Acquired vanA Resistance During Therapy

Researchers report that a bloodstream infection of methicillin-resistant Staphylococcus aureus (MRSA) in a patient with a serious skin condition acquired vancomycin resistance during antibiotic therapy.

H1N1 Predominant Flu Strain This Year

The H1N1 flu was the predominant influenza strain in the United States this year, but it packed a lot less punch than in 2009 when it caused a worldwide pandemic.

Gilead Releases Data on HCV, Advanced Liver Disease Studies

Gilead Sciences has announced data from a Phase 2 study evaluating once-daily Sovaldi (sofosbuvir) 400mg for the treatment of chronic hepatitis C virus (HCV) infection in patients with advanced liver disease.

Featured courses from mycme

Laws and Rules of the Florida Board of NursingExternal web site

This course reviews the purpose and membership of the Florida Board of Nursing (FBON), its ...

CE 2.00 Credits

Domestic Violence 3 Hour: Focus on Child Abuse for Kentucky Health ProfessionalsExternal web site

This course defines domestic violence as family violence, and further differentiates the categories of intimate ...

CE 3.00 Credits

Domestic Violence 3 Hour: Focus on Child Abuse for Florida Health ProfessionalsExternal web site

This course defines domestic violence as family violence, and further differentiates the categories of intimate ...

CE 3.00 Credits
More myCME courses »

Sign Up for Free e-newsletters